The Realities of Novel Gene Therapy Commercialization

Chris Reinhard of Cardium Therapuetics discusses ‘ the realities of novel gene therapy commercialization ‘ in this 2015 presentation . In this presentation, learn about Generx cardiac angiogenic gene therapy, a Phase III product candidate.

Download this presentation to understand more about:

  • Discovery
  • Preclinical research
  • Clinical Safety & Technology
  • Medical Utility
  • Addressable Market

and much more!

Get your copy here!

If you’re interested in learning more about emerging gene therapy candidates , join us at World Precision Medicine Congress USA 2016 , held November 14-15 in Washington, DC .

625x110

Leave a Reply

Your email address will not be published. Required fields are marked *